https://oncodaily.com/oncolibrary/lung-oncology/chemoimmunotherapy-nsclc
Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable NSCLC: What This 2026...
Apr 19, 2026 - Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC remain favorable, with low mortality but distinct operative challenges.
surgicaloutcomesnsclc
https://www.lung.org/research/clinical-trials/find-a-clinical-trial/bnt327-nsclc
BNT327 NSCLC | American Lung Association
A randomized phase 2/3 trial in first-line non-small cell lung cancer of BNT327 in combination with chemotherapy
american lung associationnsclc